Company Profile
Updated: 17-SEP-09Alseres Pharmaceuticals Inc.
Public Company, Headquarters Location
239 South St., Hopkinton, MA 01748-2208, United States
(508)497-2360, (508)497-9964 fax, http://www.alseres.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Research and development of therapeutic and diagnostic products to treat cancer, central nervous system disorders, and autoimmune diseases.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Financings Roundup.
BIOWORLD Today; 11/3/2009; 698 words; ...board. o Boston Life Sciences Inc., of Hopkinton, Mass., changed its name to Alseres Pharmaceuticals Inc. and begins trading under its...with a biopharmaceutical focus. Alseres is developing Altropane, a Phase...
Lev Raising $35 Million To Push C1 Inhibitor.
BIOWORLD Today; 11/3/2009; 978 words; Washington Editor Lev Pharmaceuticals Inc. is expecting to raise...position." Jefferies & Co. Inc. acted as lead placement...and Morgan Joseph & Co. Inc. acted as co-placement...other financing news: o Alseres Pharmaceuticals Inc...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 2026 words; o Advanced Magnetics Inc., of Cambridge, Mass., said...BioWorld Today, May 24, 2007.) o Alseres Pharmaceuticals Inc., of Hopkinton, Mass., said...methotrexate. o Columbia Laboratories Inc., of Livingston, N.J., said...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1656 words; ...treat neutropenia in cancer patients. o Alseres Pharmaceuticals Inc., of Hopkinton, Mass., and QSV Biologics...stimulate axon regeneration, was licensed by Alseres from Montreal-based BioAxone Therapeutics Inc. Financial terms were not disclosed...
Reportlinker Adds US and European Radiopharmaceuticals Market Report.
PR Newswire; 9/10/2009; 5054 words; ...and niche players such as Actinium Pharmaceuticals, Inc., Advanced Medical Isotope Corporation, Alseres Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals, Bio-Nucleonics, Inc., Bracco Diagnostics, Inc...
Recent News Articles
- Alseres Pharmaceuticals, Inc. - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Alseres Pharmaceuticals, Inc. - Financial and Strategic Analysis Review.
M2 Presswire - April 30, 2009 - Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements.
Biotech Week - April 29, 2009 - Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements.
PR Newswire - April 14, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
